| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9ba123c8e0505af3026205cb120bc00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C279-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C39-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C251-74 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C251-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C279-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C39-08 |
| filingDate |
2018-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d532139c30a8c73c721ae248a62a7d32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fb5fb843c0b2b966f615b5c053f97c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5541a0eca413de4b8599e334820c7c2 |
| publicationDate |
2020-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CZ-308447-B6 |
| titleOfInvention |
Hydrazone-based nucleotide transporters as a therapeutic tool for drug targeting for tumor immunotherapy |
| abstract |
The invention relates to a new RNA transport complex based on hydrazones usable in particular as a transport system for DNA / RNA strands or fragments across model biological membranes (PAMPA - parallel permeability analysis by an artificial membrane). The prepared transporter-RNA complexes can be used as a therapeutic tool for drug targeting for tumor immunotherapy. |
| priorityDate |
2018-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |